Patients with atopic eczema have a higher prevalence of depression and anxiety compared with patients with other chronic diseases, highlighting the importance of assessing mental health comorbidities in patients with eczema to improve quality of life (QoL) outcomes, according to study research published in the Journal of the European Academy of Dermatology and Venereology.
In this cross-sectional study, an analysis was performed on participant data in the population-based LIFE-Health Adult Study from Germany. Participants completed standardized questionnaires for depression (Centre of Epidemiologic Studies-Depression scale [CES-D]) and anxiety (Generalized Anxiety Disorder [GAD-7]). Additionally, social isolation was assessed using the Lubben Social Network Scale (LSNS), and QoL was assessed using the Short Form Health Survey-8. Psychosocial outcomes were compared in patients with atopic eczema (n=372) vs patients with other chronic diseases, including diabetes, cancer, and cardiovascular disease (n=9109).